LUPIN LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,547 INR | -2.92% |
|
-4.70% | +16.93% |
| Apr. 12 | US FDA Clears Lupin's API Plant in Gujarat, India, Following GMP Inspection | MT |
| Apr. 10 | Lupin Launches Generic Version of Oracea (Doxycycline Capsules) in US | MT |
ETFs positioned on Lupin Limited
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.38% | 6 M€ | +6.07% | - | |
| 0.12% | 11 M€ | -0.93% | ||
| 0.04% | 2,808 M€ | +2.67% | - | |
| 0.04% | 441 M€ | +1.71% | - | |
| 0.04% | 149 M€ | -1.09% | - | |
| 0.04% | 0 M€ | 0.00% | - | |
| 0.03% | 4 M€ | -4.41% | - | |
| 0.02% | 117 M€ | -1.55% | - | |
| 0.01% | 31 M€ | +1.30% | - | |
| 0.01% | 7 M€ | +19.95% | - | |
| 0.01% | 7 M€ | -0.18% | - | |
| 0.01% | 15 M€ | +5.11% | ||
| 0.00% | 34 M€ | +1.25% | - | |
| 0.00% | 389 M€ | +5.07% | - | |
| 0.00% | 34 M€ | +5.42% | - | |
| 0.00% | 16 M€ | -9.75% | ||
| 0.00% | 147 M€ | +4.13% | - | |
| 0.00% | 39 M€ | +3.09% | - | |
| 0.00% | 302 M€ | +3.37% | - | |
| 0.00% | 108 M€ | +1.02% | - | |
| 0.00% | 17 M€ | +1.06% | - | |
| 0.00% | 52 M€ | -0.79% | - | |
| 0.00% | 8 M€ | -0.64% | - |
Lupin Limited is a leading Indian pharmaceutical group. Its products are used to treat tuberculosis, diabetes, asthma, cardiovascular diseases, infections, etc. The group's activity is organized around 2 areas:
- design and production of generic and brand-name formulations;
- production of active pharmaceutical ingredients.
At the end of March 2022, the group had 15 production sites India (12), the United States, Mexico and Brazil.
Net sales break down geographically as follows: India (39.4%), the United States (34.1%) and other (26.5%).
Sector
Pharmaceuticals
Calendar
2024-05-14
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A
Sell
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
1,547
INR
Average target price
1,513
INR
Spread / Average Target
-2.18%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +16.93% | 8.69B | |
| +24.60% | 672B | |
| +24.08% | 550B | |
| -5.63% | 351B | |
| +15.37% | 317B | |
| +7.38% | 292B | |
| +3.26% | 211B | |
| +0.78% | 203B | |
| -9.69% | 144B | |
| -6.63% | 141B |
- Stock Market
- Equities
- LUPIN Stock
- Funds and ETFs Lupin Limited
